Brinker Capital Investments’s Jazz Pharmaceuticals JAZZ Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | $3.15M | Sell |
29,640
-1,311
| -4% | -$139K | 0.03% | 560 |
|
|
2025
Q1 | $3.84M | Buy |
30,951
+326
| +1% | +$40.5K | 0.04% | 431 |
|
|
2024
Q4 | $3.77M | Buy |
30,625
+8,235
| +37% | +$1.01M | 0.04% | 412 |
|
|
2024
Q3 | $2.49M | Sell |
22,390
-1,986
| -8% | -$221K | 0.02% | 581 |
|
|
2024
Q2 | $2.6M | Buy |
24,376
+3,480
| +17% | +$371K | 0.03% | 526 |
|
|
2024
Q1 | $2.52M | Buy |
20,896
+688
| +3% | +$82.8K | 0.03% | 551 |
|
|
2023
Q4 | $2.54M | Sell |
20,208
-3,518
| -15% | -$442K | 0.03% | 522 |
|
|
2023
Q3 | $3.07M | Sell |
23,726
-157
| -0.7% | -$20.3K | 0.04% | 434 |
|
|
2023
Q2 | $2.96M | Sell |
23,883
-730
| -3% | -$90.5K | 0.03% | 490 |
|
|
2023
Q1 | $3.6M | Buy |
24,613
+1,064
| +5% | +$156K | 0.04% | 354 |
|
|
2022
Q4 | $3.75M | Sell |
23,549
-34
| -0.1% | -$5.42K | 0.07% | 265 |
|
|
2022
Q3 | $3.14M | Sell |
23,583
-541
| -2% | -$72.1K | 0.07% | 289 |
|
|
2022
Q2 | $3.76M | Sell |
24,124
-1,078
| -4% | -$168K | 0.07% | 267 |
|
|
2022
Q1 | $3.92M | Buy |
25,202
+2,309
| +10% | +$359K | 0.06% | 301 |
|
|
2021
Q4 | $2.92M | Buy |
22,893
+124
| +0.5% | +$15.8K | 0.04% | 429 |
|
|
2021
Q3 | $4.05M | Hold |
22,769
| – | – | 0.06% | 322 |
|
|
2021
Q2 | $4.05M | Buy |
22,769
+10,127
| +80% | +$1.8M | 0.05% | 369 |
|
|
2021
Q1 | $2.08M | Sell |
12,642
-9,742
| -44% | -$1.6M | 0.03% | 504 |
|
|
2020
Q4 | $3.69M | Buy |
22,384
+1,939
| +9% | +$320K | 0.06% | 400 |
|
|
2020
Q3 | $2.92M | Buy |
+20,445
| New | +$2.92M | 0.05% | 354 |
|